1990 Annual Report

MARKETING SECTION The Marketing Section continued its efforts to ensure that public and private pharmaceutical reimbursement programs do not adversely affect revenues needed to finance research and development. To accomplish this, the Section worked with staff of the Health Care Systems Division to maintain effective relations with private insurers and managed-care organizations as well as with federal Medicare and Medicaid agencies, including the new Agency for Health Care Policy and Research. This new Agency was created to conduct outcomes research and to develop and disseminate practice guidelines. The Section continued to assist member companies in complying with the Prescription Drug Marketing Act of 1987. A workshop on sample tracking and accountability was held, and a new system for collecting information from physicians on samples is being tested. Section Committees also are monitoring initiatives within FDA and other groups that could lead to new guidelines on educational and promotional activities. The Marketing Section-which is composed of marketing and sales executives-is guided by a Steering Committee and has three standing committees: Marketing Research; Marketing Practices; and Developing Health Care Markets. 1990-91 CHAIRMAN Alan Steigrod Glaxo Inc. PMA STAFF LIAISON Karen Williams Vice President, Health Care Systems PMA BOARD LIAISON Paul E. Freiman MEDICAL SECTION The Medical Section took a leading role in helping to update the FDA's Clinical Guidelines. The Section also worked on clinical research problems of general interest, clinical study requirements for product approvals and the medical aspects of the drug evaluation and approval process. In addition, the Section focused on medical manpower and training problems and on the relationship of the pharmaceutical industry to professional societies. 4The Section-which is composed of physicians-has a number of committees. They are: Clinical Safety Surveillance; Clinical Trials/Clinical Pharmacology; Consultants to the Steering Committee; Drug Labeling, Advertising and Information; Special xm nPopulations Issues; Education and Training; International Medical Affairs; Medical RelaStions; Nomination and Membership; and Program. 1990-91 CHAIRMAN William R. Darrow, M.D., Ph.D. Schering-Plough Corp. PMA STAFF LIAISON PMA BOARD LIAISON John C. Petricciani, M.D. Sheldon G. Gilgore, M.D. Vice President, Medical and Regulatory Affairs 23

/ 36

Actions

file_download Download Options Download this page PDF - Pages #1-36 Image - Page 23 Plain Text - Page 23

About this Item

Title
1990 Annual Report
Author
Pharmaceutical Research and Manufacturers of America
Canvas
Page 23
Publication
Pharmaceutical Manufacturers Association
1990
Subject terms
reports
Item type:
reports

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0504.028
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0504.028/25

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0504.028

Cite this Item

Full citation
"1990 Annual Report." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0504.028. University of Michigan Library Digital Collections. Accessed June 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel